🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Effectiveness of Chatbot-Supported Web Program in Postpartum Care

RecruitingNAAges 18 Years - 35 YearsFemaleEmine Ilkin Aydin
NCT07148778 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

The purpose of this clinical study was to evaluate the effectiveness of a web-based "Postpartum Care Package" program developed for postpartum women and delivered via a chatbot, and to examine its effects on the postpartum health of mothers and newborns. The key questions it aims to answer are: * What is the impact of the chatbot-supported web-based "Postpartum Care Package" program on the postpartum health of mothers and newborns? * Does the chatbot-supported web-based "Postpartum Care Package" program increase women's accessibility and availability of postpartum care resources?

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: Women who will be included in the study. * Have given birth between the 37th and 41st weeks of pregnancy, * Be primigravida, * Have not been diagnosed with a high-risk pregnancy, * Have an educational level of primary school or above, * Have no communication difficulties or mental disabilities, * Have access to equipment (mobile phone, computer, tablet, internet) for web-based education, * Have experienced no complications in the mother or baby during pregnancy, childbirth, or the postpartum period, * Voluntarily agree to participate in the study, Exclusion Criteria: * Women who moved outside the province where the study was conducted during the implementation period, * Women who voluntarily withdrew from the study, * Women who did not participate in any phase of the study will not be included in the study.
💊

What it tests

  • Educational intervention
📍

Where

1 site
Yozgat City Hospital
Yozgat, Turkey (Türkiye)
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy